EC approves ViiV Healthcare’s Dovato to treat HIV-1 infection

This article was originally published here

Dovato is a new once-daily, single-pill and two-drug regimen approved for the treatment of HIV-1 infection in adults and adolescents above 12 years of age weighing at least

The post EC approves ViiV Healthcare’s Dovato to treat HIV-1 infection appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply